Search Results

BeiGene Medical Europe

Search results for 'Ibrutinib':

Exploring the changing landscape in Waldenström’s macroglobulinaemia: How will emerging BTK inhibitors alter patient outcomes?
 lecture   08/2020
Exploring the changing landscape in Waldenström’s macroglobulinaemia: How will emerging BTK inhibitors alter patient outcomes?
ASPEN: Results of a Phase 3 Randomized Trial of Zanubrutinib versus Ibrutinib for Patients with Waldenström Macroglobulinemia (EHA)
 abstract   06/2020
ASPEN: Results of a Phase 3 Randomized Trial of Zanubrutinib versus Ibrutinib for Patients with Waldenström Macroglobulinemia (EHA)
BeiGene Presents Updated Head to Head Results from Phase 3
 pdf   06/2020
BeiGene Presents Updated Head to Head Results from Phase 3
Trial in progress: a phase 2, multicenter, single-arm study of zanubrutinib (BGB-3111) in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma intolerant of prior treatment with ibrutinib
 abstract   06/2020
Trial in progress: a phase 2, multicenter, single-arm study of zanubrutinib (BGB-3111) in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma intolerant of prior treatment with ibrutinib
Zanubrutinib vs. Ibrutinib in R/R CLL/SLL
 image   06/2020
Zanubrutinib vs. Ibrutinib in R/R CLL/SLL
A phase 2, multicenter, single-arm of Zanubrutinib
 pdf   06/2020
A phase 2, multicenter, single-arm of Zanubrutinib
Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL
 image   06/2020
Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL
Results of a phase 3 randomized trial of Zanubrutinib vs. Ibrutinib
 abstract   06/2020
Results of a phase 3 randomized trial of Zanubrutinib vs. Ibrutinib
Zanubrutinib vs. Ibrutinib in WM
 image   06/2020
Zanubrutinib vs. Ibrutinib in WM
ASPEN: Results of a Phase 3 Randomized Trial of Zanubrutinib versus Ibrutinib for Patients with Waldenström Macroglobulinemia (ASCO)
 abstract   06/2020
ASPEN: Results of a Phase 3 Randomized Trial of Zanubrutinib versus Ibrutinib for Patients with Waldenström Macroglobulinemia (ASCO)

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service
Meet now